Baruch Future Ventures
Thomas Baruch joined the Calysta Board of Directors in 2013 and was named Executive Chairman of the Board in 2014. He retired in 2014 from Formation 8, where he was a founding member and chairman. Mr. Baruch formed CMEA Capital in 1988 with New Enterprise Associates (NEA). He was responsible for managing a total of $1.2 billion of capital across seven funds from inception to July of 2010. While at CMEA, Mr. Baruch also led investments including major IPO’s and significant liquidity events for Aclara Biosciences, Codexis, Inc., Entropic Communications, Flextronics, Inc., Intermolecular, Silicon Spice and Symyx Technologies. He is now Partner Emeritus of CMEA. Earlier in his career, Mr. Baruch worked at Exxon Mobil for 12 years. When he left in 1982, he was serving as President of the Exxon Materials Division. Next, he founded Microwave Technology, Inc., a manufacturer and seller of gallium arsenide (GaAs) integrated circuits for defense applications. Mr. Baruch served as CEO for 6 years prior to founding CMEA Capital.
Currently, Mr. Baruch serves as Chairman of the Board of Codexis, Inc. (NASDAQ: CDXS) and Intermolecular, Inc. (NASDAQ: IMI). Mr. Baruch also currently serves on the boards of CNano Technologies, Exela Pharm Sci, Foro Energy and Wildcat Discovery Technologies.
Mr. Baruch is a member of the National Advisory Council on Innovation and Entrepreneurship (NACIE), where he advises the U.S. Department of Commerce and the White House. Mr. Baruch is a member of the Executive Committee of the U.S. Council of Competitiveness and a member of the Steering Committee of its ESIS (Energy, Security, Innovation and Sustainability) Initiative and the U.S. Manufacturing Competitiveness Initiative. Mr. Baruch is also a member of the “Brain Trust” of the ARPA-E program within the U.S. Department of Energy. Mr. Baruch recently served as a member of the IPO Task Force advising the U.S. Department of the Treasury in connection with necessity of programs to stimulate startup activity in the U.S. Mr. Baruch is also a member of the board of directors of the Society of Kauffman Fellows, a member of the Climate Recovery Cabinet of the Sierra Club, and a trustee of the “That Man May See” program within the University of California San Francisco. Mr. Baruch is an advisor to Hasso Plattner Ventures, a leading German venture capital fund. He has recently joined the Board of CASE, Rensselaer Polytechnic Institute’s Center for Architecture Science and Ecology.
In addition, Mr. Baruch is a Trustee of the Rensselaer Polytechnic Institute where he was Co-Chairman of its recent $1.1 billion Capital Campaign. He and his wife, Johanna, are Founders of the Baruch Center for Solar Biochemical Energy Research at the School of Science of Rensselaer Polytechnic Institute and the Richard Baruch, M.D. Endowed Chair in metabolic pathways of the School of Biotechnology and Interdisciplinary Studies.
Mr. Baruch holds an engineering degree from Rensselaer Polytechnic Institute and a Juris Doctor degree from Capital University. He is a member of the State Bar of Ohio and is a registered patent attorney.
Craig Barratt, Ph.D.
Craig Barratt, Ph.D., a leading consumer electronics entrepreneur, joined the Calysta Board of Directors in 2013. He is CEO of Barefoot Networks, a developer of ultra fast networking equipment. Prior to joining Barefoot, he was VP of Access and Energy at Google. He was previously the president of Qualcomm Atheros, the network and connectivity subsidiary of Qualcomm (NASDAQ:QCOM).
Dr. Barratt joined Qualcomm in 2011 following its acquisition of Atheros Communications, a fabless semiconductor company. From 2003, he was president, CEO and a director of Atheros. He led the company through its 2004 IPO and growth to over $900 million in revenue in 2010.
Dr. Barratt previously served as Atheros’ vice president of technology from 2002 until 2003. Prior to joining Atheros, he held the role of executive vice president and general manager of ArrayComm, a company specializing in multi-antenna signal processing. He also serves on the Board of Directors at Intuitive Surgical (NASDAQ: ISRG), a pioneer in robotic assisted surgery.
Dr. Barratt holds Ph.D. and Master of Science degrees in electrical engineering from Stanford University, as well as a Bachelor of Engineering degree in electrical engineering and a Bachelor of Science degree from the University of Sydney in Australia. Dr. Barratt has been granted over 30 patents in a variety of wireless and related technologies and has co-authored a book on linear controller design, various technical publications and open source software.
Walden Riverwood Ventures
Nicholas Brathwaite joined the Calysta Board of Directors in 2015. He is a founding partner of Riverwood Capital. Nicholas has spent over 25 years developing and evaluating technology. From 1996 to 2007, he Served as the Chief Technology Officer at Flextronics, where he worked alongside Michael Marks, former CEO. At Flextronics, Nicholas was innovative in his drive to move the company into product development, and he oversaw the launch and growth of several of Flextronics’ largest business units.
Previously, he was a founding member of nChip responsible for development of the industry-leading advanced multi-chip module assembly process. More recently with Riverwood, Nicholas served as the interim CEO for Aptina Imaging from February 2007 to August 2008. His unique combination of technology know-how and commercial judgment will add value throughout the investment life-cycle at Riverwood. Nicholas earned an M.Sc. Degree in Polymer Science Engineering from the University of Waterloo, Canada and a B.Sc.(Honors) Degree in Applied Chemistry from McMaster University, Canada. He is a director of Globant, Arkmicro, Power Integrations, Tessera Technologies, Inc. and Chairman of the Board of Aptina Imaging.
Hitoshi Kudo joined the Calysta Board of Directors in 2017. Mr. Kudo is the General Manager, Animal Nutrition Department, Nutriscience Division in the Nutrition and Agriculture Business Unit of Mitsui & Co., Ltd. He has global responsibility for feed additives and animal health. Previously, he served as General Manager for Mitsui’s Fourth Agriscience Department, with responsibility for business development in the areas of crop protection and feed additives. He joined Mitsui in 1992 and has held a variety of management positions in chemical and agricultural business development and finance. Mr. Kudo holds a bachelor’s degree in economics from Hitotsubashi University and an MBA from the University of Illinois at Urbana-Champaign.
MERS of Michigan
Edward Mikolay joined the Calysta Board of Directors in 2016. He is a Senior Investment Officer and Director of Private Markets for the Municipal Employee Retirement System (MERS) of Michigan. In this role, he is responsible for new investment origination and oversight of the private investment portfolio, including private equity, real assets (infrastructure, energy, real estate, and agriculture/farmland) and diversifying strategies. Mr. Mikolay is a voting member of the Portfolio Review Committee, which is responsible for all portfolio management decisions, including asset manager selection and strategic asset allocation implementation. Mr. Mikolay serves on a number of private partnership advisory boards and is a frequent speaker at industry conferences.
Mr. Mikolay joined MERS in 2013 and has nearly 20 years of investment experience, most recently as a portfolio manager at the State of Michigan Retirement Systems (SMRS) in its Real Estate and Infrastructure Division. At SMRS, Mr. Mikolay was involved in a variety of portfolio management roles, including sourcing and underwriting new investments, overseeing dispositions and representing SMRS during partnership restructurings. He was also active on the advisory boards of many of those investments. Before his employment with SMRS, Mr. Mikolay was a real estate investment professional at CB Richard Ellis in Grand Rapids, Michigan. He has also held roles in real estate acquisitions at Heitman Capital Management, a pension fund advisory firm, and Equity Residential Properties Trust (NYSE: EQR), both based in Chicago.
Mr. Mikolay is a graduate of Brown University (Providence, RI) with a Bachelor of Arts degree in mathematical economics. He also earned a Masters of Business Administration degree from the Kellogg Graduate School of Management at Northwestern University (Evanston, IL), with majors in Finance, Entrepreneurship, and Real Estate.
Alan Shaw, Ph.D., President and Chief Executive Officer
Alan Shaw, Ph.D., is President and Chief Executive Officer of Calysta, and a member of the Board of Directors. He joined in 2012. Dr. Shaw is a veteran biotechnology entrepreneur and chemical industry executive, with more than 25 years experience building and leading technology companies.
Before joining Calysta, he served for ten years as President & CEO and a director of Codexis, a developer of cost-advantaged processes for production of biofuels, biobased chemicals and pharmaceuticals. During his tenure, Codexis completed an IPO and expanded from a startup to a global industrial biotechnology company with operations in the United States, Europe and Asia.
In 2010, Dr. Shaw received the Ernst and Young Entrepreneur® of the Year Award in the life sciences category for Northern California. He serves as a biotechnology advisor to the governments of the United Kingdom and Malaysia, and is a frequent speaker on energy to leading business and industry conferences.
Prior to Codexis, Dr. Shaw held senior operating and business development positions in the United Kingdom for Chiroscience Group plc and for the chemical and biopharmaceutical units of Clariant and BTP plc from 1994-99. For the previous 15 years, he held management and scientific leadership positions for Imperial Chemical Industries plc (ICI)/Zeneca, including Business Head, Fine Chemicals and Marketing Manager, European Sales. Dr. Shaw is a past board member of BIO and chair of BIO’s industrial and environmental section. He holds a bachelor’s degree in chemistry from Teesside University and a Ph.D. in chemistry from the University of Durham, England, and is a fellow of the Royal Society of Chemistry.
Brian Silvey joined the Calysta Board in 2016. As Vice President and Director of Global Bioindustrials for Cargill, Mr. Silvey is responsible for the global strategy, business development and client management to drive business growth and market share. Mr. Silvey has more than 35 years of leadership experience at Cargill, with a particularly strong focus on business development, operations, management, and marketing.
Before taking his current role, Mr. Silvey managed Cargill’s bioethanol, citric acid and industrial starch product lines; sustainability efforts; joint ventures; and onsite partnerships for Cargill Starches & Sweeteners North America business division. Prior to that he oversaw Cargill’s facility in Blair, Neb., one of the largest Cargill corn milling operations globally. Over the course of his career, Mr. Silvey has served in a variety of leadership roles, including assistant vice president of Aligned Products for Corn Milling in Blair, Neb., and president/general manager of Cargill Rice Milling in Greenville, Miss. Mr. Silvey began his Cargill career in 1979 as a Los Angeles-based commodity trader.
Mr. Silvey holds a Bachelor of Arts degree from Harvard University. Currently, he serves on the Board of Directors for NouriTech, Calysta and Rivertop Renewables. Throughout his career, Mr. Silvey has been active on numerous community boards and in various industry associations.
Suan Swee Tan
Tan Suan Swee joined the Calysta Board of Directors in 2017. He is Managing Director, Investments of Temasek International, overseeing the agribusiness and biosciences sectors. At Temasek, Mr. Tan has been involved in several investment deals in agribusiness, life sciences and energy. He is presently on the board of the Pavilion Energy group, which is importing and trading in natural gas; Cargill Tropical Palm, a joint venture with Cargill; and Jilin Food Zone which is developing an industrial park in China. Outside Singapore, Mr. Tan is on the board of companies which own stakes in Ceva Sante, an animal health products company based in France and Zuellig Pharma, the largest distributor of pharmaceutical products in Asia. Mr. Tan is also on the board of Temasek Life Sciences Laboratory, an R&D institute focusing on research in plant and animal sciences.
Prior to joining Temasek in 2003, Mr. Tan was Assistant Managing Director of Singapore’s Economic Development Board (EDB). In his 16 years at EDB, he headed the energy and chemical industry clusters, and biomedical sciences. He also led the board’s European Operations. He was a principal player in the development of Jurong Island as a hub for the chemical industry.
Mr Tan holds a Bachelor’s Degree in Chemical Engineering from the University of Adelaide, South Australia on a Colombo Plan Scholarship and an MBA from the National University of Singapore.
Mike Velings joined the Calysta Board of Directors and the Advisory Board in 2015. He is the founder and the driving force behind Aqua-Spark, a global investment fund for sustainable aquaculture, combining a healthy financial profit with environmental and social impact. A lifelong entrepreneur, Mike has spent decades jumpstarting a range of successful businesses. Among other ventures, he co-founded Connexie, which has helped catalyze a professional employment industry across the Netherlands. Mike naturally combines his business background with environmental and social engagement. He understands the potential for business to create durable solutions to complex world problems. With this in mind, Mike founded A-Spark: an investment company that assists entrepreneurs across the globe in realizing their visions of a start-up with a world-changing element. Through A-Spark he has invested in a broad range of ventures over the years– both in the developed and developing world. Mike serves on several boards and is also a member of the Chairman’s Council of Conservation International and an Honorary Global Marine Fellow.